Epidemiology, Treatment, and Outcomes of Juvenile Idiopathic Arthritis-Associated Uveitis: A Multi-Institutional Study in Taiwan

References

• Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392.
   PubMed Web of Science ®Google Scholar
• Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138–2149. doi:10.1016/S0140-6736(11)60244-4.
   PubMed Web of Science ®Google Scholar
• Hawkins MJ, Dick AD, Lee RJW, et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol. 2016;61(2):197–210. doi:10.1016/j.survophthal.2015.10.005.
   PubMed Web of Science ®Google Scholar
• Edelsten C, Lee, V, Bentley, CR, Kanski, JJ, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86(1):51–56. doi:10.1136/bjo.86.1.51.
   PubMed Web of Science ®Google Scholar
• Woreta F, Thorne, JE, Jabs, DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647–655. doi:10.1016/j.ajo.2006.11.025.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019;58(6):975–986. doi:10.1093/rheumatology/key406.
   PubMed Web of Science ®Google Scholar
• Rypdal V, Glerup M, Songstad NT, et al. Uveitis in juvenile idiopathic arthritis: 18-year outcome in the population-based Nordic cohort study. Ophthalmology. 2021;128(4):598–608. doi:10.1016/j.ophtha.2020.08.024.
   PubMed Web of Science ®Google Scholar
• Shen CC, Yeh K-W, Ou L-S, et al. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol Immunol Infect. 2013;46(4):288–294. doi:10.1016/j.jmii.2012.03.006.
   PubMedGoogle Scholar
• Yu HH, Chen P-C, Wang L-C, et al. Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan. PLoS One. 2013;8(8):e70625. doi:10.1371/journal.pone.0070625.
   PubMed Web of Science ®Google Scholar
• Consolaro A, Giancane G, Alongi A, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–263. doi:10.1016/S2352-4642(19)30027-6.
   PubMedGoogle Scholar
• Jari M, Shiari R, Salehpour O, et al. Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15(1):41. doi:10.1186/s13023-020-1324-x.
   PubMed Web of Science ®Google Scholar
• Quartier P, Baptiste A, Despert V, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of Adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77(7):1003–1011. doi:10.1136/annrheumdis-2017-212089.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Mesquida M, Adán A, et al. Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2016;43(12):2183–2188. doi:10.3899/jrheum.160231.
   PubMed Web of Science ®Google Scholar
• Zulian F, Balzarin M, Falcini F, et al. Abatacept for severe anti–tumor necrosis factor α refractory juvenile idiopathic arthritis–related uveitis. Arthritis Care Res (Hoboken). 2010;62(6):821–825. doi:10.1002/acr.20115.
   PubMed Web of Science ®Google Scholar
• Shao SC, Chan -Y-Y, Kao Yang Y-H, et al. The chang gung research database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593–600. doi:10.1002/pds.4713.
   PubMed Web of Science ®Google Scholar
• Tsai MS, Lin M-H, Lee C-P, et al. Chang Gung research database: a multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263–269. doi:10.1016/j.bj.2017.08.002.
   PubMed Web of Science ®Google Scholar
• Shih YJ, Yang Y-H, Lin C-Y, et al. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. Pediatr Rheumatol Online J. 2019;17(1):58. doi:10.1186/s12969-019-0363-0.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol Online J. 2015;13(1):19. doi:10.1186/s12969-015-0018-8.
   PubMedGoogle Scholar
• Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015;159(2):372–7.e1. doi:10.1016/j.ajo.2014.11.007.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46(6):1015–1019. doi:10.1093/rheumatology/kem053.
   PubMed Web of Science ®Google Scholar
• British Society for Paediatric and Adolescent Rheumatology and Royal College of Ophthalmology. Guidelines for Screening for Uveitis in Juvenile Idiopathic Arthritis. 2006. https://www.rcophth.ac.uk/wp-content/uploads/2022/02/2006_PROF_046_JuvenileArthritis-updated-crest-2.pdf.
   Google Scholar
• Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American college of rheumatology/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2019;71(6):703–716. doi:10.1002/acr.23871.
   PubMed Web of Science ®Google Scholar
• Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107–1117. doi:10.1136/annrheumdis-2018-213131.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Woreta FA, Dunn JP, et al. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2020;127(4s):S21–s26. doi:10.1016/j.ophtha.2020.01.036.
   PubMedGoogle Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/NEJMoa1614160.
   PubMed Web of Science ®Google Scholar
• Tynjälä P, Lindahl P, Honkanen V, et al. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2007;66(4):548–550. doi:10.1136/ard.2006.058248.
   PubMed Web of Science ®Google Scholar
• Schmeling H, Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44(8):1008–1011. doi:10.1093/rheumatology/keh658.
   PubMed Web of Science ®Google Scholar
• Saurenmann RK, Levin AV, Feldman BM, et al. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents. J Pediatr. 2006;149(6):833–836. doi:10.1016/j.jpeds.2006.08.044.
   PubMed Web of Science ®Google Scholar
• Sobrin L, Pistilli M, Dreger K, et al. Factors predictive of remission of chronic anterior uveitis. Ophthalmology. 2020;127(6):826–834. doi:10.1016/j.ophtha.2019.11.020.
   PubMed Web of Science ®Google Scholar
• Artornsombudh P, Pistilli M, Foster CS, et al. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 2014;121(3):778–784. doi:10.1016/j.ophtha.2013.09.041.
   PubMed Web of Science ®Google Scholar
• Acharya NR, Patel S, Homayounfar G, et al. Relapse of juvenile idiopathic arthritis-associated uveitis after discontinuation of immunomodulatory therapy. Ocul Immunol Inflamm. 2019;27(4):686–692. doi:10.1080/09273948.2018.1424341.
   PubMed Web of Science ®Google Scholar
• Simonini G, Bracaglia C, Cattalini M, et al. Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis. J Rheumatol. 2017;44(6):822–826. doi:10.3899/jrheum.161336.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, van de Winkel EL, Rothova A, et al. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011;151(2):217–222. doi:10.1016/j.ajo.2010.08.021.
   PubMed Web of Science ®Google Scholar
• Lerman MA, Lewen MD, Kempen JH, et al. Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol. 2015;160(1):193–200.e1. doi:10.1016/j.ajo.2015.04.016.
   PubMed Web of Science ®Google Scholar
• Saboo US, Metzinger JL, Radwan A, et al. Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. J Aapos. 2013;17(5):460–464. doi:10.1016/j.jaapos.2013.06.004.
   PubMed Web of Science ®Google Scholar
• Sijssens KM, Rothova A, Berendschot TTJM, et al. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113(5):853–9.e2. doi:10.1016/j.ophtha.2006.01.043.
   PubMed Web of Science ®Google Scholar
• Stroh IG, Moradi A, Burkholder BM, et al. Occurrence of and risk factors for ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2017;25(4):503–512. doi:10.3109/09273948.2016.1142573.
   PubMed Web of Science ®Google Scholar
• Al Rubaie K, Al Dhahri H, Al Fawaz A, et al. Incidence and risk factors for developing glaucoma among patients with uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2016;24(5):571–578. doi:10.3109/09273948.2015.1047036.
   PubMed Web of Science ®Google Scholar
• Ayuso VK, ten Cate HAT, van der Does P, et al. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):987–993. doi:10.1016/j.ajo.2010.01.014.
   PubMed Web of Science ®Google Scholar
• Ayuso VK, Ten Cate HA, Van der Does P, et al. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):994–999.e5. doi:10.1016/j.ajo.2010.01.016.
   PubMed Web of Science ®Google Scholar
• Suelves AM, Lamba N, Meese HK, et al. Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis. J Aapos. 2016;20(3):232–238.e1. doi:10.1016/j.jaapos.2016.02.010.
   PubMed Web of Science ®Google Scholar
• Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14(1):27. doi:10.1186/s12969-016-0088-2.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Minden K, Föll D, et al. Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int. 2015;112(6):92–100. doi:10.3238/arztebl.2015.0092.
   PubMed Web of Science ®Google Scholar